Security key
67080M103
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)
CUSIP: 67080M103
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 851,276
- Total 13F value
- $20,652,376
- Share change
- +219,731
- SEC-reported price per share
- $24.26
- Number of holders
- 7
- Value change
- +$5,330,731
- Number of buys
- 4
- Number of sells
- 1
- Shares outstanding
- 103,174,603
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
7
Top holders
7
NRIX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Nurix Therapeutics, Inc. SEC filings
Nurix Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080M103
Recent filing periods:
Ownership snapshot
Top reported holders of NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
20 Apr 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Redmile Group, LLC
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
9.9%
BlackRock, Inc.
8.2%
BAKER BROS. ADVISORS LP
7.2%
Vestal Point Capital, LP
6.3%
Deep Track Capital, LP
6.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13D/G
13F
Company
|
9.9%
|
$165,792,867
10,696,314 shares
|
$0 | 20 Apr 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
8.2%
from 13D/G
|
$138,347,454
8,925,642 shares
|
— | 31 Mar 2026 |
| BAKER BROS. ADVISORS LP |
13D/G
13F
Company
|
7.2%
|
$138,364,566
7,527,996 shares
|
$0 | 31 Dec 2025 |
| Vestal Point Capital, LP |
13D/G
13F
Company
|
6.3%
|
$100,815,000
6,500,000 shares
|
$0 | 31 Mar 2026 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
6.2%
|
$98,414,734
6,345,244 shares
|
+$13,109,734 | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
5.4%
|
$85,945,115
5,541,271 shares
|
+$21,424,444 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
851,276
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
194
Q2 2026 holders
7
Holder diff
-187
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend